Intel shares faced pronounced selling pressure as investors reacted to escalating concerns regarding execution timelines in its manufacturing roadmap and continued competitive displacement across core computing markets. Market participants have grown increasingly cautious about the pace of the turnaround within Intel Foundry, where substantial capital expenditure commitments continue to weigh heavily on free cash flow and near-term gross margin profiles. Emerging concerns over extended customer qualification cycles for advanced process nodes have further heightened skepticism regarding the speed at which external foundry revenue can meaningfully offset internal operational cost burdens.

Compounding the pressure on the manufacturing…